Gene therapy in vascular surgery comes of age

Surgery

Volumn 131, Issue 1 SUPPL., 2002, Pages

  Yonemitsu, Yoshikazu ^a   Komori, Kimihiro ^a   Sueishi, Katsuo ^a   Sugimachi, Keizo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; FIBROBLAST GROWTH FACTOR 2; GENE PRODUCT; MYC PROTEIN; NITRIC OXIDE SYNTHASE; OLIGONUCLEOTIDE; PROTEIN C MYB; PROTEIN P21; PROTEIN P27; PROTEIN P53; SCATTER FACTOR; TRANSCRIPTION FACTOR; VASCULOTROPIN;

ADENOVIRUS; ARTICLE; CELL PROLIFERATION; DNA VECTOR; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUMAN; LIMB ISCHEMIA; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESTENOSIS; SENDAI VIRUS; TUMOR SUPPRESSOR GENE; VASCULAR DISEASE; VASCULAR SURGERY; VEIN GRAFT;

EID: 0036163296     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2002.119967     Document Type: Article

References (65)

1. Recombinant gene expression in vivo within endothelial cells of the arterial wall
2. Implantation of vascular grafts lined with genetically modified endothelial cells
3. Autogenous vein grafting femoropopliteal atherosclerosis
4. Intimal hyperplasia in autogenous veins used for arterial replacement
5. Late graft failure in vein grafts: Mediating factors in subendothelial fibromuscular hyperplasia
6. Effect of diminished distal blood flow on the morphologic changes in autogenous vein grafts
7. Development and regression of intimal thickening of arterially transplanted autologous vein grafts in dogs
8. Mechanical factors predisposing to intimal hyperplasia and medial thickening in autogenous vein grafts
9. Intimal hyperplasia of experimental autologous vein graft in hyperlipidemic rabbits with poor distal runoff
10. Gene therapy for vascular smooth muscle cell proliferation after arterial injury
11. Reduction of restenosis after angioplasty in an atheromatous rabbit model by suicide gene therapy
12. Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries
13. Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury
14. Novel intraluminal molecular delivery of antisense cdc2 kinase and PCNA oligonucleotide inhibits neointimal hyperplasia
15. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides
16. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo
17. Sp1 decoy transfected to carcinoma cells suppresses the expression of vascular endothelial growth factor, transforming growth factorβ1, and tissue factor and also cell growth and invasion activities
18. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retino-blastoma gene product
19. Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neo-intima formation in the rat carotid artery model of balloon angioplasty
20. Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury
21. Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery
22. Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo
23. p53 gene transfer to the injured rat carotid artery decreases neointimal formation
24. Adenovirus-mediated transfer of a dominant-negative H-ras suppresses neointimal formation in balloon-injured arteries in vivo
25. Recombinant Sendai virus-mediated gene transfer to vasculature: A new class of efficient gene transfer vector to the vascular system
26. Gene transfer into normal and atherosclerotic human blood vessels
27. Local expression of C-type natriuretic peptide markedly suppresses neointimal formation in rat injured arteries through an autocrine/paracrine loop
28. Gene therapy inhibiting neointimal vascular lesion: In vivo gene transfer of endothelial cell nitric oxide synthase gene
29. Overexpression of human endothelial nitric oxide synthase in vascular smooth muscle cells and in balloon-injured carotid artery
30. Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats
31. Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs
32. Improvement of relaxation in an atherosclerotic artery by gene transfer of endothelial nitric oxide synthase
33. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery
34. Low level in vivo gene transfer into the arterial wall through a perforated balloon catheter
35. In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries
36. Percutaneous arterial gene transfer in a rabbit model: Efficiency in normal and balloon-dilated atherosclerotic arteries
37. Characterization of in vivo gene transfer into the arterial wall mediated by the Sendal virus (hemagglutinating virus of Japan) liposomes: An effective tool for the in vivo study of arterial diseases
38. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury
39. Vascular endothelial growth factor enhances atherosclerotic plaque progression
40. The rate of reendothelialization correlates inversely with the degree of the following intimal thickening in vein grafts. Electron microscopic and immunohistochemical studies
41. Immunohistochemical phenotypic alterations of rabbit autologous vein grafts implanted under arterial circulation with or without poor distal runoff-implications of vein graft remodeling
42. Diversity of the synthetic-state smooth-muscle cells proliferating in mechanically and hemodynamically injured rabbit arteries
43. Adenoviral-mediated gene transfer of a constitutively active form of the retinoblastoma gene product attenuates neointimal thickening in experimental vein grafts
44. HVJ-liposome-mediated gene transfer of endothelial cell nitric oxide synthase inhibits intimal hyperplasia of canine vein grafts under conditions of poor runoff
45. Gene therapy of restenosis: Promise and perils
46. Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model
47. Restenosis after experimental angioplasty. Intimal, medial, and adventitial changes associated with constrictive remodeling
48. Remodeling rather than neointimal formation explains luminal narrowing after deep vessel wall injury: Insights from a porcine coronary (re)stenosis model
49. Quantitative assessment with intracoronary ultrasound of the mechanisms of restenosis after percutaneous transluminal coronary angioplasty and directional coronary atherectomy
50. Arterial remodeling after coronary angioplasty: A serial intravascular ultrasound study
51. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model
52. Late graft failure of autologous vein grafts for arterial occlusion disease, clinical and experimental studies
53. Computational simulation method of intraluminal velocity profile proved by laser Doppler velocimeter
54. Correlation of long-term results of femoropopliteal autogenous vein grafts with shear stress variations: In situ or reversed grafts?
55. Correlation of long-term results of extra-anatomical bypass and flow waveform analysis
56. Simulated blood flow and the effects on prostacyclin production in the dog femoral artery
57. The reversibility of impaired prostacyclin production of the vein graft
58. Angiopoietin-1 protects the adult vasculature against plasma leakage
59. VEGF gene delivery to myocardium: Deleterious effects of unregulated expression
60. VEGF gene therapy: Stimulating angiogenesis or angioma-genesis?
61. Serious adverse effect of intramuscular gene transfer of VEGF165 for limb salvage in mice with critical limb ischemia
62. Abnormal blood vessel development and lethality in embryos lacking a single vascular endothelial growth factor allele
63. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor
64. VEGF gene delivery to muscle: Potential role for vasculogenesis in adults
65. Efficient gene transfer to the airway epithelium using recombinant Sendai virus